Literature DB >> 18618093

[Tremor. Differential diagnosis and treatment].

H Wilms1, J Raethjen.   

Abstract

Tremor is one of the most frequent neurological signs; the diagnosis is mainly clinical. The most frequent tremor is essential tremor, which manifests itself as a postural and kinetic tremor. Tremor may occur not only in the hands, but also in the head and voice. Parkinsonian tremor is a tremor at rest; the legs and face are frequently involved. Orthostatic tremor mainly manifests itself in the legs and gives rise to postural instability. Dystonic tremor is an action tremor of the affected region of the body. Drug therapy mostly depends on the clinical manifestation. Postural and action tremors respond to beta blockers, primidone, some antiepileptics and benzodiazepines. Classical rest tremors are improved by dopaminergic substances or anticholinergics. Dystonic tremor may be successfully treated by injecting botulinum toxin. Orthostatic tremor responds to gabapentin or benzodiazepines in some patients. In patients with severely disability, implantation of thalamic stimulation electrodes may be considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618093     DOI: 10.1007/s00115-008-2453-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

1.  Tremor in multiple sclerosis.

Authors:  S H Alusi; S Glickman; T Z Aziz; P G Bain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

2.  Specificity of ethanol in essential tremor.

Authors:  A H Rajput
Journal:  Ann Neurol       Date:  1996-12       Impact factor: 10.422

3.  Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor.

Authors:  G Deuschl; R Wenzelburger; K Löffler; J Raethjen; H Stolze
Journal:  Brain       Date:  2000-08       Impact factor: 13.501

4.  Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  T A Zesiewicz; R Elble; E D Louis; R A Hauser; K L Sullivan; R B Dewey; W G Ondo; G S Gronseth; W J Weiner
Journal:  Neurology       Date:  2005-06-22       Impact factor: 9.910

5.  Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.

Authors:  J Raethjen; S Pohle; R B Govindan; A Morsnowski; R Wenzelburger; G Deuschl
Journal:  Exp Neurol       Date:  2005-07       Impact factor: 5.330

6.  Diagnostic and pathophysiological aspects of psychogenic tremors.

Authors:  G Deuschl; B Köster; C H Lücking; C Scheidt
Journal:  Mov Disord       Date:  1998-03       Impact factor: 10.338

7.  Re-emergent tremor of Parkinson's disease.

Authors:  J Jankovic; K S Schwartz; W Ondo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

Review 8.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Blinded placebo crossover study of gabapentin in primary orthostatic tremor.

Authors:  Julian P Rodrigues; Dylan J Edwards; Susan E Walters; Michelle L Byrnes; Gary W Thickbroom; Rick Stell; Frank L Mastaglia
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.